DEK Is a Poly(ADP-Ribose) Acceptor in Apoptosis and Mediates Resistance to Genotoxic Stress
Kappes, F., Fahrer, J., Khodadoust, M. S., Tabbert, A., Strasser, C., Mor-Vaknin, N., Moreno-Villanueva, M., Bürkle, A., Markovitz, D. M., Ferrando-May, E.
Published in Molecular and Cellular Biology (01.05.2008)
Published in Molecular and Cellular Biology (01.05.2008)
Get full text
Journal Article
Clinical activity of ponatinib in a patient with FGFR1-rearranged mixed-phenotype acute leukemia
Khodadoust, M S, Luo, B, Medeiros, B C, Johnson, R C, Ewalt, M D, Schalkwyk, A S, Bangs, C D, Cherry, A M, Arai, S, Arber, D A, Zehnder, J L, Gotlib, J
Published in Leukemia (01.04.2016)
Published in Leukemia (01.04.2016)
Get full text
Journal Article
Genomic abnormalities involving class I HLA are common in advanced cutaneous T‐cell lymphoma
Kwang, A. C, Duran, G. E., Li, S., Torres, A. N. Bastidas, Herrera, M., Wang, E. B., Kurtz, D. M., Kim, Y. H., Khodadoust, M. S.
Published in Hematological oncology (01.06.2023)
Published in Hematological oncology (01.06.2023)
Get full text
Journal Article
A PHASE II TRIAL OF REDUCED DOSE BRENTUXIMAB VEDOTIN FOR CUTANEOUS T‐CELL LYMPHOMAS
Khan, N., Noor, S., Geller, S., Khodadoust, M. S., Kheterpal, M., Hancock, H., Davey, T., Ryu, S., Perez, L., Lares, A., Ganesan, N., Sohail, S., Santarosa, A., Galasso, N., Kim, E., Myskowski, P., Kim, Y. H., Horwitz, S., Moskowitz, A.
Published in Hematological oncology (01.06.2021)
Published in Hematological oncology (01.06.2021)
Get full text
Journal Article
DETERMINANTS OF RESISTANCE TO ENGINEERED T‐CELL THERAPIES TARGETING CD19 IN LYMPHOMA
Sworder, B, Kurtz, D. M, Alig, S, Frank, M. J, Macauley, C. W, Garofalo, A, Shukla, N, Sahaf, B, Esfahani, M. S, Sheybani, N, Schroers-Martin, J, Liu, C. L, Olsen, M., Spiegel, J. Y, Oak, J, Jin, M. C, Beygi, S, Khodadoust, M. S, Natkunam, Y, Majzner, R, Mackall, C. L, Diehn, M, Miklos, D. M, Alizadeh, A. A
Published in Hematological oncology (01.06.2021)
Published in Hematological oncology (01.06.2021)
Get full text
Journal Article
THE COMBINATION OF DUVELISIB AND ROMIDEPSIN (DR) IS HIGHLY ACTIVE AGAINST RELAPSED/REFRACTORY PERIPHERAL T‐CELL LYMPHOMA WITH LOW RATES OF TRANSAMINITIS: FINAL RESULTS
Horwitz, S. M., Moskowitz, A. J., Mehta‐Shah, N., Jacobsen, E. D., Khodadoust, M. S., Ganesan, N., Drill, E., Hancock, H., Davey, T., Myskowski, P., Maccaro, C., Blouin, W., Schwieterman, J., Cathcart, E., Fang, S., Perez, L., Ryu, S., Galasso, N., Straus, D., Fisher, D. C., Kumar, A., Noy, A., Falchi, L., Dogan, A., Kim, Y. H., Weinstock, D.
Published in Hematological oncology (01.06.2021)
Published in Hematological oncology (01.06.2021)
Get full text
Journal Article
S262: THE COBALT‐LYM STUDY OF CTX130: A PHASE 1 DOSE ESCALATION STUDY OF CD70‐TARGETED ALLOGENEIC CRISPR‐CAS9–ENGINEERED CAR T CELLS IN PATIENTS WITH RELAPSED/REFRACTORY (R/R) T‐CELL MALIGNANCIES
Iyer, S. P., Sica, R. A., Ho, P. J., Hu, B., Zain, J., Prica, A., Weng, W.‐K., Kim, Y. H., Khodadoust, M. S., Palomba, M. L, Foss, F. M., Tipton, K., Cullingford, E. L., He, Q., Sharma, A., Horwitz, S. M.
Published in HemaSphere (01.06.2022)
Published in HemaSphere (01.06.2022)
Get full text
Journal Article
LACUTAMAB IN PATIENTS WITH ADVANCED MYCOSIS FUNGOIDES (MF): EFFICACY RESULTS ACCORDING TO UPDATED LYMPH NODE (LN) CLASSIFICATION IN THE TELLOMAK STUDY
Kim, Y. H., Bagot, M., Ortiz‐Romero, P. L., Zinzani, P. L., Beylot‐Barry, M., Dalle, S., Jacobsen, E., Combalia, A., Huen, A., Mehta‐Shah, N., Khodadoust, M. S., Mehta, A., Dereure, O., Battistella, M., Gru, A., Moins‐Teisserenc, H., Viotti, J., Paiva, C., Boyer‐Chammard, A., Porcu, P.
Published in Hematological oncology (01.06.2023)
Published in Hematological oncology (01.06.2023)
Get full text
Journal Article
LACUTAMAB IN PATIENTS WITH ADVANCED MYCOSIS FUNGOIDES (MF): EFFICACY RESULTS ACCORDING TO UPDATED LYMPH NODE (LN) CLASSIFICATION IN THE TELLOMAK STUDY
Kim, Y. H., Bagot, M., Ortiz‐Romero, P. L., Zinzani, P. L., Beylot‐Barry, M., Dalle, S., Jacobsen, E., Combalia, A., Huen, A., Mehta‐Shah, N., Khodadoust, M. S., Mehta, A., Dereure, O., Battistella, M., Gru, A., Moins‐Teisserenc, H., Viotti, J., Paiva, C., Boyer‐Chammard, A., Porcu, P.
Published in Hematological oncology (01.06.2023)
Published in Hematological oncology (01.06.2023)
Get full text
Journal Article
Clinical characteristics, treatment patterns, and outcomes of cytotoxic cutaneous T-cell lymphomas
Mou, D, Fernandez-Pol, S, Li, S, Kim, Y, Khodadoust, MS
Published in European journal of cancer (1990) (01.09.2022)
Published in European journal of cancer (1990) (01.09.2022)
Get full text
Journal Article
Lacutamab in patients with advanced mycosis fungoides according to KIR3DL2 expression: stage 1 results from the TELLOMAK phase 2 trial
Bagot, M, Muller, M, Kim, YH, Ortiz-Romero, PL, Zinzani, PL, Beylot-Barry, M, Dalle, S, Jacobsen, E, Combalia, A, Huen, A, Mehta-Shah, N, Khodadoust, MS, Viotti, J, Paiva, C, Porcu, P
Published in European journal of cancer (1990) (01.09.2022)
Published in European journal of cancer (1990) (01.09.2022)
Get full text
Journal Article
The COBALT-LYM study of CTX130: a phase 1 dose escalation study of CD70-targeted allogeneic CRISPR-Cas9–engineered CAR T cells in patients with relapsed/refractory (R/R) T-cell malignancies
Zain, DR, Iyer, SP, Sica, RA, Ho, PJ, Hu, B, Prica, A, Weng, W-K, Kim, YH, Khodadoust, MS, Palomba, ML, Foss, FM, Tipton, K, Cullingford, EL, Horwitz, SM, Sharma, A
Published in European journal of cancer (1990) (01.09.2022)
Published in European journal of cancer (1990) (01.09.2022)
Get full text
Journal Article
IPH4102, a first-in-class anti-KIR3DL2 monoclonal antibody, in patients with relapsed or refractory cutaneous T-cell lymphoma: an international, first-in-human, open-label, phase 1 trial
Bagot, Martine, Prof, Porcu, Pierluigi, Prof, Marie-Cardine, Anne, PhD, Battistella, Maxime, MD, William, Basem M, MD, Vermeer, Maarten, Prof, Whittaker, Sean, Prof, Rotolo, Federico, PhD, Ram-Wolff, Caroline, MD, Khodadoust, Michael S, MD, Bensussan, Armand, PhD, Paturel, Carine, PhD, Bonnafous, Cecile, PhD, Sicard, Helene, PhD, Azim, Hatem A, MD, Kim, Youn H, Prof
Published in The lancet oncology (01.08.2019)
Published in The lancet oncology (01.08.2019)
Get full text
Journal Article
A PHASE I/II TRIAL OF IBRUTINIB, INTRATUMORAL CPG AND LOCAL RADIATION IN PATIENTS WITH LOW‐GRADE B‐CELL LYMPHOMA: INTERIM CLINICAL AND CORRELATIVE RESULTS
Shree, T., Khodadoust, M.S., Czerwinski, D., Frank, M.J., Hong, W.X., Greenstein, R., Long, S., Martin, B., Levy, R.
Published in Hematological oncology (01.06.2019)
Published in Hematological oncology (01.06.2019)
Get full text
Journal Article
Low-Dose Total Skin Electron Beam Therapy Combined With Mogamulizumab for Refractory Mycosis Fungoides and Sézary Syndrome
Fong, Sophia, Hong, Eric K., Khodadoust, Michael S., Li, Shufeng, Hoppe, Richard T., Kim, Youn H., Hiniker, Susan M.
Published in Advances in radiation oncology (01.05.2021)
Published in Advances in radiation oncology (01.05.2021)
Get full text
Journal Article
Duvelisib, an oral dual PI3K‐δ,γ inhibitor, efficacy and safety in patients with relapsed or refractory (RR) peripheral T‐cell lymphoma: rationale for the phase 2 PRIMO trial
Horwitz, S.M., Foss, F.M., Porcu, P., Moskowitz, A., Mehta‐Shah, N., Jacobsen, E., Khodadoust, M.S., Kim, Y.H., Weinstock, D., Lustgarten, S., Baglio, M., Youssoufian, H., Brammer, J.
Published in Hematological oncology (01.06.2019)
Published in Hematological oncology (01.06.2019)
Get full text
Journal Article
O3 High-dimensional analysis of tumor architecture predicts cancer immunotherapy response
Schürch, C M, Phillips, D J, Matusiak, M, B Rivero Gutierrez, Bhate, S S, Barlow, G L, Khodadoust, MS, West, R, Kim, Y H, Nolan, G P
Published in Journal for immunotherapy of cancer (01.10.2020)
Published in Journal for immunotherapy of cancer (01.10.2020)
Get full text
Journal Article
p300/CBP-associated Factor Drives DEK into Interchromatin Granule Clusters
Cleary, Joanne, Sitwala, Kajal V., Khodadoust, Michael S., Kwok, Roland P.S., Mor-Vaknin, Nirit, Cebrat, Marek, Cole, Philip A., Markovitz, David M.
Published in The Journal of biological chemistry (09.09.2005)
Published in The Journal of biological chemistry (09.09.2005)
Get full text
Journal Article
Value of Surveillance Studies for Patients With Stage I to II Diffuse Large B-Cell Lymphoma in the Rituximab Era
Hiniker, Susan M., MD, Pollom, Erqi L., MD, Khodadoust, Michael S., MD, PhD, Kozak, Margaret M., BA, Xu, Guofan, MD, PhD, Quon, Andrew, MD, Advani, Ranjana H., MD, Hoppe, Richard T., MD
Published in International journal of radiation oncology, biology, physics (01.05.2015)
Published in International journal of radiation oncology, biology, physics (01.05.2015)
Get full text
Journal Article
DEK expression in melanocytic lesions
Kappes, Ferdinand, PhD, Khodadoust, Michael S., MD, PhD, Yu, Limin, MD, Kim, David S.L., MD, PhD, Fullen, Douglas R., MD, Markovitz, David M., MD, Ma, Linglei, MD, PhD
Published in Human pathology (01.07.2011)
Published in Human pathology (01.07.2011)
Get full text
Journal Article